3 Promising Penny Stocks With Market Caps Over $70M
Expensify, Inc. Class A EXFY | 0.00 |
Over the last 7 days, the United States market has risen 1.1%, contributing to a substantial 27% increase over the past year, with earnings projected to grow by 17% annually. The term 'penny stocks' might feel like a relic of past market eras, but the potential they represent is as real as ever. Typically referring to smaller or relatively new companies, these stocks can provide a mix of affordability and growth potential when paired with strong financials.
Top 10 Penny Stocks In The United States
| Name | Share Price | Market Cap | Rewards & Risks |
| ZJK Industrial (ZJK) | $2.88 | $180.1M | ✅ 3 ⚠️ 2 View Analysis > |
| WM Technology (MAPS) | $0.385 | $64.99M | ✅ 2 ⚠️ 5 View Analysis > |
| LexinFintech Holdings (LX) | $2.02 | $341.11M | ✅ 3 ⚠️ 2 View Analysis > |
| Tuya (TUYA) | $2.17 | $1.38B | ✅ 4 ⚠️ 1 View Analysis > |
| FinVolution Group (FINV) | $4.94 | $1.25B | ✅ 4 ⚠️ 1 View Analysis > |
| Information Services Group (III) | $3.11 | $203.8M | ✅ 3 ⚠️ 0 View Analysis > |
| Golden Growers Cooperative (GGRO.U) | $5.00 | $77.45M | ✅ 2 ⚠️ 5 View Analysis > |
| Niagen Bioscience (NAGE) | $3.80 | $300.09M | ✅ 3 ⚠️ 1 View Analysis > |
| BAB (BABB) | $0.9416 | $6.91M | ✅ 2 ⚠️ 3 View Analysis > |
| Marine Petroleum Trust (MARP.S) | $4.975 | $10M | ✅ 2 ⚠️ 3 View Analysis > |
We'll examine a selection from our screener results.
Alto Ingredients (ALTO)
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Alto Ingredients, Inc. is involved in the production, distribution, and marketing of specialty alcohols, renewable fuel, and essential ingredients in the United States with a market cap of $355.66 million.
Operations: No specific revenue segments are reported for this company.
Market Cap: $355.66M
Alto Ingredients has shown financial improvement, achieving profitability with a net income of US$4.27 million in the first quarter of 2026, compared to a loss the previous year. The company trades at a significant discount to estimated fair value and maintains satisfactory debt levels, though its interest coverage is below ideal thresholds. Despite high volatility in share price recently, Alto's short-term assets cover both short and long-term liabilities comfortably. The board and management teams are experienced, contributing to strategic stability as evidenced by their recent US$150 million shelf registration filing for potential future capital raising efforts.
Wrap Technologies (WRAP)
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Wrap Technologies, Inc. is a public safety technology and services company that develops policing solutions for law enforcement and security personnel globally, with a market cap of $79.92 million.
Operations: Currently, there are no specific revenue segments reported for the company.
Market Cap: $79.92M
Wrap Technologies has reported a revenue increase to US$1.11 million for Q1 2026, though it remains unprofitable with a net loss of US$4.54 million. The company is debt-free and its short-term assets exceed liabilities, offering some financial stability despite having less than a year of cash runway. Recent strategic partnerships and client acquisitions, such as the Carolina Beach Police Department's purchase of BolaWrap devices, indicate growing interest in its non-lethal response solutions. However, challenges remain with an inexperienced board and negative return on equity, highlighting potential risks for investors in this volatile penny stock space.
Expensify (EXFY)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Expensify, Inc. offers a cloud-based expense management software platform serving both the United States and international markets, with a market cap of $108.98 million.
Operations: The company generates revenue of $140.00 million from its Internet Software & Services segment.
Market Cap: $108.98M
Expensify, Inc. is navigating challenges typical of penny stocks, with recent earnings showing a net loss of US$2.34 million for Q1 2026 despite revenue of US$33.97 million. The company remains unprofitable and has received a Nasdaq deficiency notice due to its stock trading below the minimum bid price requirement, prompting consideration of a reverse stock split to maintain listing compliance. Positively, Expensify is debt-free and has sufficient cash runway for over three years, supported by positive free cash flow. A share repurchase program aims to stabilize volatility and potentially enhance shareholder value amidst ongoing financial challenges.
Where To Now?
- Take a closer look at our US Penny Stocks list of 358 companies by clicking here.
- Interested In Other Possibilities? The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 16 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
